Anti-E3 SUMO-protein ligase PIAS4 antibody (ab38622)


  • Product nameAnti-E3 SUMO-protein ligase PIAS4 antibody
    See all E3 SUMO-protein ligase PIAS4 primary antibodies
  • Description
    Rabbit polyclonal to E3 SUMO-protein ligase PIAS4
  • Tested applicationsSuitable for: ELISA, WB, IHC-Pmore details
  • Species reactivity
    Reacts with: Human, Recombinant Fragment
  • Immunogen

    Synthetic peptide conjugated to KLH, taken from a C terminal sequence within aa486-499 of Human PAIAS gamma.

  • Positive control
    • Human breast carcinoma tissue.



Our Abpromise guarantee covers the use of ab38622 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesELISA: 1/1000.
    IHC-P: 1/50 - 1/100.
    WB: 1/100 - 1/500. Detects a band of approximately 81 kDa (bacterial).

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionFunctions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway, the p53 pathway, the Wnt pathway and the steroid hormone signaling pathway. Involved in gene silencing. Promotes PARK7 sumoylation. In Wnt signaling, represses LEF1 and enhances TCF4 transcriptional activities through promoting their sumoylations.
    • Tissue specificityHighly expressed in testis and, at lower levels, in spleen, prostate, ovary, colon and peripheral blood leukocytes.
    • PathwayProtein modification; protein sumoylation.
    • Sequence similaritiesBelongs to the PIAS family.
      Contains 1 PINIT domain.
      Contains 1 SAP domain.
      Contains 1 SP-RING-type zinc finger.
    • DomainThe LXXLL motif is a coregulator signature that is essential for transcriptional corepression.
    • Post-translational
      Sumoylated. Lys-35 is the main site of sumoylation. Sumoylation is required for TCF4 sumoylation and transcriptional activitation. Represses LEF1 transcriptional activity. SUMO1 is the preferred conjugate.
    • Cellular localizationNucleus > PML body. Colocalizes with SUMO1 and TCF7L2/TCF4 and LEF1 in a subset of PML (promyelocytic leukemia) nuclear bodies.
    • Information by UniProt
    • Database links
    • Alternative names
      • E3 SUMO protein ligase PIAS4 antibody
      • E3 SUMO-protein ligase PIAS4 antibody
      • FLJ12419 antibody
      • MGC35296 antibody
      • PAIASgamma antibody
      • PIAS 4 antibody
      • PIAS gamma antibody
      • PIAS-gamma antibody
      • Pias4 antibody
      • PIAS4_HUMAN antibody
      • PIASG antibody
      • PIASgamma antibody
      • PIASy antibody
      • Protein inhibitor of activated STAT 4 antibody
      • Protein inhibitor of activated STAT protein 4 antibody
      • Protein inhibitor of activated STAT protein gamma antibody
      • Protein inhibitor of activated STAT protein PIASy antibody
      • Zinc finger MIZ type containing 6 antibody
      • ZMIZ 6 antibody
      • ZMIZ6 antibody
      see all

    Anti-E3 SUMO-protein ligase PIAS4 antibody images

    • Anti-E3 SUMO-protein ligase PIAS4 antibody (ab38622) + Recombinant GST-PIASy-1(81.4 kDa) in bacterial cell lysate.
    • ab38622 staining human cancer tissue by immunohistochemistry, formalin-fixed, paraffin-embedded tissue. The breast carcinoma tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining.

    References for Anti-E3 SUMO-protein ligase PIAS4 antibody (ab38622)

    ab38622 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab38622.
    Please use the links above to contact us or submit feedback about this product.